The options arrangement gives me a fear of a 2 year tenure with a smash and grab mentality - and exiting saying ' I converted an R&D comapny into a revenue focused one'...how much revenue? Who the hell knows what the revenue benchamark is? ... $100k per quarter?
I sure to hell hope his vision isnt as short sighted as the Option strike prices....
Unfortuantley my cynicism is amplifying as the days go buy with no contracts signed - which were elluded to many many times across the biotech and energy divisions.
Ann: Notice of Annual General Meeting/Proxy Form, page-168
-
- There are more pages in this discussion • 210 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
